Skip to main content

fluvoxamine

Generic: FLUVOXAMINE MALEATE·Brand: FLUVOXAMINE MALEATE, LUVOX, LUVOX CR

fluvoxamine: sourced relationships with 2 companies · 2 clinical trials tracked · 3 FDA decisions.

fluvoxamine evidence translation

What we can confirm

3 FDA records · 2 tracked trials

What it means

More than one company relationship is source-backed. Until you choose one, AI stays drug-only and does not guess ownership.

What to watch

Watch active trials and any change in FDA or trial status.
BioSniper AIPage evidence connected

Prepared research question

What is verified about fluvoxamine, and what remains unknown?

Run cited research

Traceable citations · Unknowns marked

Dated Pipeline Records (2)
CompanyDated record stage
ANI PHARMACEUTICALS INC (ANIP)
Reported 2007-12-20 · Current development: unknownSource
Approved
Jazz Pharmaceuticals plc (JAZZ)
Reported 2008-04-14 · Current development: unknownSource
Approved
Clinical Trial Registry Records (2)

COVID-OUT: Early Outpatient Treatment for SARS-CoV-2 Infection (COVID-19)

NCT04510194Registry updated 2026-04-24·Phase 3
Completed

Primary endpoint: Clinical Progression to Severe Covid

InterventionalRandomizedquadruple1,323 enrolledStarted 2021-01Completion 2022-127 sites · United StatesUniversity of Minnesota

Pharmacokinetics and Safety of Commonly Used Drugs in Lactating Women and Breastfed Infants

NCT03511118Registry updated 2026-02-11·N/A
Recruiting

Primary endpoint: M/P ratio

Observational1,600 targetStarted 2018-10Completion 2027-0722 sites · Canada, United StatesDuke University
FDA Decisions3 records
NDA022235Type 6 - New Indication (no longer used)StandardOralTablet
NDA022033Type 3 - New Dosage FormStandardOralCapsule, Extended Release
NDA021519Type 3 - New Dosage FormStandardOralTablet

Frequently asked questions

Which companies have sourced relationships with fluvoxamine?

fluvoxamine has dated SEC/FDA relationship records for ANI PHARMACEUTICALS INC, Jazz Pharmaceuticals plc.

How many clinical trials involve fluvoxamine?

BioSniper tracks 2 clinical trials involving fluvoxamine.

What is fluvoxamine's latest FDA decision?

The most recent tracked FDA decision for fluvoxamine is Approval, dated April 14, 2008.